New Drug Keeps 84% of Cancer Patients on Full Treatment
A groundbreaking therapy helps cancer patients maintain their full chemotherapy doses by protecting platelet counts, keeping treatment on track when every dose matters. The phase 3 trial shows romiplostim could transform how doctors manage one of chemotherapy's toughest side effects.